Stock LOVE CANNARA BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Cannara Biotech Inc. Canadian Securities Exchange

Equities

LOVE

CA13765U1012

Delayed Canadian Securities Exchange
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Cannara Biotech Inc. -.--% +87.50%
04-29 Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51% MT
04-29 Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cannara Biotech Reports Q2 2024 Financial Results
AQ
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans
AQ
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
AQ
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
PR
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII
NE
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan
PR
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share
AQ
Cannara Announces Proposed Share Consolidation
AQ
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
AQ
Cannara Releases 14 New SKU's Across Ontario and Quebec
AQ
Cannara Biotech : OTCB Certification YE 2021
PU
Cannara Biotech : Q1 2022 Cannara Biotech Inc. Financial Statements
PU
Cannara Biotech : Q1 2022 Cannara Biotech Inc. MD&A
PU
Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results
AQ
Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022
PR
Cannara Biotech : OTCB Certification YE 2021
PU
Cannara Biotech : OTCBQ Certification YE 2021
PU
Cannara Biotech : Annual MD&A 2021
PU
Cannara Biotech : Financial statement 2021
PU
Cannara Biotech : 52-109FV1 - Certification of annual filings - CFO (E)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LOVE Stock
  4. LOVE Stock
  5. News Cannara Biotech Inc.
  6. Press Releases